Drug reps today are facing an increasingly strong imperative to depart from traditional promotional activities simply aimed at getting doctors’ prescriptions. For these reps to shift to communications focusing on proper drug use, the key will be their performance reviews.…
HOME > ACADEMIA
ACADEMIA
- Japan Pediatric Society Launches New Scheme to Promote Development of Pediatric Drugs, Prevent Drug Lag
January 11, 2018
- Japan Dermatological Association Opposes Restrictions on Hirudoid Prescriptions, Warns against Hasty Decision
December 27, 2017
- Neurology Society Revises Epilepsy Treatment Guidelines; Adding Zonisamide as 1st-Line Drug for Partial Onset Seizures
December 12, 2017
- Neurology Society Revises Parkinson’s Disease Treatment Guidelines, Emphasizing L-Dopa-Based Early Treatment
December 12, 2017
- In Renewed Attempt, Tokushima Univ. Starts IIT for Eisai-Dropped ALS Drug Candidate
November 9, 2017
- Japan’s 1st Constipation Treatment Guidelines Recommend Drugs Acting on Epithelial Function Including Amitiza
October 25, 2017
- Nephrology Society to Build Database, Biobank to Support Drug Discovery; Some 20 Companies Interested in Collaboration
October 13, 2017
- AMED Study Group to Investigate Drugs to Recommend in Elderly Depression Patients; Findings to Be Reflected in New Guidelines
September 7, 2017
- Over 150 Clinical Trials of Epigenetic Drugs, Some with Novel Mechanisms of Action, Underway Worldwide
August 31, 2017
- Opdivo-Induced Myasthenia Gravis Tends to Become Severe: Keio Researchers
August 21, 2017
- Japan Gastric Cancer Association to Wait for Opdivo Nod before Guidelines Update, Keytruda Won’t Make It This Time
August 16, 2017
- NCCHD to Launch Panel to Study Real-World Drug Use in Children, Findings Might Be Used for Label Revisions
August 8, 2017
- Kyoto Univ. to Commence Trial of Drug Candidate Discovered in iPS Cells Research for Rare Bone Disease
August 3, 2017
- Drug Vial Optimization Reduces Drug Expenditure, with Biggest Savings for Opdivo: Study
August 2, 2017
- Hypertension Treatment Guidelines for Elderly Finalized with Recommendations on Dosage Reduction, Discontinuation
July 21, 2017
- JSHR to Conduct 20-Year Follow-Up Study in Up to 100,000 Patients to Determine Efficacy of H. Pylori Eradication Therapy at Preventing Stomach Cancer
July 14, 2017
- New Treatment GL for Advanced HCC to Be Issued in October, Will Recommend Nexavar for 1st-Line Treatment
July 11, 2017
- Cure Can Be Expected Now for Colon Cancer Due to Advances in Pharmacotherapy: Oncologist
July 5, 2017
- Long-Term Safety of PCSK9 Inhibitors Remains to Be Determined: New Atherosclerosis Prevention Guidelines
July 4, 2017
- Japanese Society of Hypertension to Verify Results of SPRINT Study
June 14, 2017
ページ
Eisai is aiming to notch up a compound annual growth rate (CAGR) of 20% over FY2020-2025 under its five-year business plan. The primary driver will certainly be Lenvima (lenvatinib), a fast-growing cancer drug that has earned an up-to-US$5.76 billion alliance…
Nearly a year after the introduction of the Ministry of Health, Labor and Welfare’s (MHLW) drug promotion guidelines in April…
Advancements in modified oligonucleotide technologies has been the key driver behind a spate of approvals in the oligonucleotide therapeutics space…
Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…
The Ministry of Health, Labor and Welfare (MHLW) on November 27 added to the NHI price list Japan’s first biosimilars of Avastin (bevacizumab), Nesp (darbepoetin alfa), and Forteo (teriparatide). The NHI prices of first biosimilars are set at 70% of…
A total of 51 new drugs joined the NHI price list in 2019, which are expected to generate combined peak sales of 373 billion yen, according to Jiho’s tally of data submitted to a key reimbursement policy panel. The relatively…
Some seven years in the making, Japan’s Ministry of Health, Labor and Welfare (MHLW) finally rolled out a cost-effectiveness assessment…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…
Look into the heart of every successful company, the businesses that have made a real impact on the world, and you’ll notice they all share a common trait.The people. But not just any people, as Jim Collins famously said…“People are…